Translation of "médicament pour " (French → English) :

over-the-counter drug [ non-prescription drug | non-prescription medicinal product | OTC drug | OTC medicine | over-the-counter medicine ]

medicament [ medication ]

ethical drug | medicinal product subject to medical prescription | prescription drug | prescription medicine | prescription only medicine | prescription-only medicinal product | Rx drug | POM [Abbr.]

European Medicines Agency [ EMA [acronym] European Agency for the Evaluation of Medicinal Products ]

innovator brand | originator | originator brand | originator medicinal product | originator medicine | originator pharmaceutical | originator pharmaceutical product | originator product

Food and Drug Administration | United States Food and Drug Administration | US Food and Drug Administration | FDA [Abbr.] | US FDA [Abbr.]

controlled-release drug

prescription drug | prescription medication | prescription medicine | prescribed drug | ethical drug | ethic drug | legend drug

administer prescriptions for medication in dentistry | determine indications for use of medication in dental practice | write prescriptions for dentistry medication | write prescriptions for medication in dentistry

catastrophic drug

The categories concerned should be medicinal products which aim at the treatment, prevention or medical diagnosis of seriously debilitating or life-threatening diseases, or medicinal products to be used in emergency situations in response to public health threats recognised either by the World Health Organisation or by the Community in the framework of Decision No 2119/98/EC of the European Parliament and of the Council of 24 September 1998 setting up a network for the epidemiological surveillance and control of communicable diseases in the Community , or medicinal products designated as orphan medicinal products in accordance with Regul ...[+++]ation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products

In establishing these rules, a distinction should be made between investigational medicinal products (the tested product and its reference products, including placebos) and auxiliary medicinal products (medicinal products used in the context of a clinical trial but not as investigational medicinal products), such as medicinal products used for background treatment, challenge agents, rescue medication, or used to assess end-points in a clinical trial.

Generic medicinal products, medicinal products authorised under the provisions relating to well-established medicinal use, authorised homeopathic medicinal products and authorised herbal medicinal products should be subject to a reduced annual fee, as those medicinal products generally have a well-established safety profile.

In establishing these rules, a distinction should be made between investigational medicinal products (the tested product and its reference products, including placebos) and auxiliary medicinal products (medicinal products used in the context of a clinical trial but not as investigational medicinal products), such as medicinal products used for background treatment, challenge agents, rescue medication, or used to assess end-points in a clinical trial.